Lung Cancer Screening
482,50 kr
På lager
ISBN
9781626235137
Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol. Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking.
| Forfatter | Günter Germann |
|---|---|
| Forlag | Thieme Medical Publishers |
| Indbinding | Paperback |
| Varegruppe | Medicin, Sundhed og Sygdom |
| Ekspedition | SVB |
| Udgivelsesdato | 13. dec. 2017 |
| Sideantal | 120 |
| Bredde | 0 |
| Højde | 0 |
| Dybde | 0 |
| Vægt | 0 |
| Første udgave | 2017 |
| Oplagsdato | 13. dec. 2017 |
| Oplag | 1 |
| Udgave | 1 |
| ISBN-13 | 9781626235137 |
| ISBN-10 | 1626235139 |
| EAN | 9781626235137 |
| Sprog | Engelsk |
| Orignalsprog | Sproget kan ikke bestemmes |
| Illustreret i farver/sh | Nej |




